微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.35% | 40% | -79.17% | 86/140 | 1.2% | 健帆生物 | 9.87% | 行业排名> |
| 2025-12-31 | 1.68% | 15.07% | 0% | 84/140 | 2.37% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-09-30 | 1.68% | -13.4% | 409.09% | 89/140 | 4.19% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-06-30 | 0.33% | -73.6% | 32% | 95/140 | 2.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-03-31 | 0.25% | -69.51% | -82.88% | 100/140 | 1.42% | 惠泰医疗 | 15.03% | 行业排名> |
| 2024-12-31 | 1.46% | -79.83% | -24.74% | 88/140 | 4.14% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-09-30 | 1.94% | -74.54% | 55.2% | 89/140 | 5.03% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-06-30 | 1.25% | -75.63% | 52.44% | 85/140 | 3.15% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-03-31 | 0.82% | -73.2% | -88.67% | 81/140 | 1.75% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2023-12-31 | 7.24% | -56.59% | -4.99% | 59/140 | 5.44% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-09-30 | 7.62% | -42.71% | 48.54% | 44/140 | 6.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-06-30 | 5.13% | -37.44% | 67.65% | 46/140 | 3.96% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-03-31 | 3.06% | -35.98% | -81.65% | 42/140 | 2.33% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2022-12-31 | 16.68% | -14.81% | 25.41% | 38/140 | 13.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-09-30 | 13.3% | -8.59% | 62.2% | 38/140 | 13.94% | 九安医疗 | 146.56% | 行业排名> |
| 2022-06-30 | 8.2% | 1.11% | 71.55% | 42/140 | 9.74% | 九安医疗 | 140.94% | 行业排名> |
| 2022-03-31 | 4.78% | 58.28% | -75.59% | 33/140 | 6.8% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 19.58% | 65.09% | 34.57% | 42/140 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-09-30 | 14.55% | 65.72% | 79.41% | 40/140 | 16.59% | 热景生物 | 121.78% | 行业排名> |
| 2021-06-30 | 8.11% | 93.56% | 168.54% | 51/140 | 11.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-03-31 | 3.02% | 104.05% | -74.54% | 54/140 | 6.49% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 11.86% | 325.09% | 35.08% | 81/140 | 26.27% | 热景生物 | 57.63% | 行业排名> |
| 2020-09-30 | 8.78% | 341.21% | 109.55% | 57/140 | 19.98% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 4.19% | 791.49% | 183.11% | 78/140 | 15.17% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-03-31 | 1.48% | 179.25% | -46.95% | 50/140 | 3.31% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 2.79% | 257.69% | 40.2% | 102/140 | 14.66% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-09-30 | 1.99% | -8.72% | 323.4% | 60/140 | 10.54% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 0.47% | -48.91% | -11.32% | 71/140 | 6.76% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-03-31 | 0.53% | -26.39% | -32.05% | 50/140 | 2.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 0.78% | -71.74% | -64.22% | 101/140 | 14.23% | 新华医疗 | 13.55% | 行业排名> |
| 2018-09-30 | 2.18% | -41.24% | 136.96% | 51/140 | 9.71% | 安旭生物 | 48.71% | 行业排名> |
| 2018-06-30 | 0.92% | -61.98% | 27.78% | 52/140 | 4.54% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-03-31 | 0.72% | -59.09% | -73.91% | 45/140 | 2.78% | *ST明德 | 14.54% | 行业排名> |
| 2017-12-31 | 2.76% | -58.74% | -25.61% | 90/140 | 14.51% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-09-30 | 3.71% | -42.03% | 53.31% | 39/140 | 9.49% | 安旭生物 | 59.22% | 行业排名> |
| 2017-06-30 | 2.42% | -42.65% | 37.5% | 49/140 | 6.11% | 大博医疗 | 30.55% | 行业排名> |
| 2017-03-31 | 1.76% | -40.94% | -73.69% | 30/140 | 2.74% | 基蛋生物 | 23.11% | 行业排名> |
| 2016-12-31 | 6.69% | -49.51% | 4.53% | 65/140 | 16.44% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-09-30 | 6.4% | -32.2% | 51.66% | 23/140 | 8.86% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 4.22% | -41.55% | 41.61% | 31/140 | 6.35% | 安图生物 | 28% | 行业排名> |
| 2016-03-31 | 2.98% | -21.58% | -77.51% | 12/140 | 2.3% | *ST明德 | 23.29% | 行业排名> |